{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:10:38Z","timestamp":1783721438839,"version":"3.55.0"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800599"],"award-info":[{"award-number":["81800599"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20180145"],"award-info":[{"award-number":["BK20180145"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0802700"],"award-info":[{"award-number":["2019YFA0802700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Hypoxia inducible factors (HIFs) and their regulatory hydroxylases the prolyl hydroxylase domain enzymes (PHDs) are the key mediators of the cellular response to hypoxia. HIFs are normally hydroxylated by PHDs and degraded, while under hypoxia, PHDs are suppressed, allowing HIF-\u03b1 to accumulate and transactivate multiple target genes, including erythropoiesis, and genes participate in angiogenesis, iron metabolism, glycolysis, glucose transport, cell proliferation, survival, and so on. Aiming at stimulating HIFs, a group of small molecules antagonizing HIF-PHDs have been developed. Of these HIF-PHDs inhibitors (HIF-PHIs), roxadustat (FG-4592), daprodustat (GSK-1278863), vadadustat (AKB-6548), molidustat (BAY 85-3934) and enarodustat (JTZ-951) are approved for clinical usage or have progressed into clinical trials for chronic kidney disease (CKD) anemia treatment, based on their activation effect on erythropoiesis and iron metabolism. Since HIFs are involved in many physiological and pathological conditions, efforts have been made to extend the potential usage of HIF-PHIs beyond anemia. This paper reviewed the progress of preclinical and clinical research on clinically available HIF-PHIs in pathological conditions other than CKD anemia.<\/jats:p>","DOI":"10.3389\/fphar.2022.837249","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T09:04:12Z","timestamp":1645693452000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Mengqiu","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanjun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1681\/ASN.2019060623","article-title":"Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in Ckd Patients with Anemia on Hemodialysis in Japan","volume":"31","author":"Akizawa","year":"","journal-title":"J. Am. Soc. Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000502012","article-title":"Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease","volume":"143","author":"Akizawa","year":"","journal-title":"Nephron"},{"key":"B3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000496929","article-title":"A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial","volume":"49","author":"Akizawa","year":"","journal-title":"Am. J. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2215\/CJN.16011219","article-title":"Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia: A Randomized, Double-Blind, Phase 3 Trial","volume":"15","author":"Akizawa","year":"","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e026602","DOI":"10.1136\/bmjopen-2018-026602","article-title":"Molidustat for the Treatment of Renal Anaemia in Patients with Dialysis-dependent Chronic Kidney Disease: Design and Rationale of Three Phase Iii Studies","volume":"9","author":"Akizawa","year":"","journal-title":"BMJ Open"},{"key":"B6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/1744-9987.13468","article-title":"Oral Roxadustat Three Times Weekly in ESA-Na\u00efve and ESA-Converted Patients with Anemia of Chronic Kidney Disease on Hemodialysis: Results from Two Phase 3 Studies","volume":"24","author":"Akizawa","year":"","journal-title":"Ther. Apher. Dial."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1016\/j.ekir.2021.07.015","article-title":"Molidustat for Japanese Patients with Renal Anemia Receiving Dialysis","volume":"6","author":"Akizawa","year":"","journal-title":"Kidney Int. Rep."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.13724","article-title":"Two Long\u2010term Phase 3 Studies of Enarodustat ( JTZ \u2010951) in Japanese Anemic Patients with Chronic Kidney Disease Not on Dialysis or on Maintenance Hemodialysis: SYMPHONY ND\u2010Long and HD\u2010Long Studies","author":"Akizawa","year":"","journal-title":"Ther. Apher. Dial."},{"key":"B9","doi-asserted-by":"publisher","first-page":"42027","DOI":"10.1074\/jbc.M111.303222","article-title":"Regulation of Cellular Levels of Sprouty2 Protein by Prolyl Hydroxylase Domain and Von Hippel-Lindau Proteins","volume":"286","author":"Anderson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1056\/NEJMc1913712","article-title":"Roxadustat for Anemia in Patients with Chronic Kidney Disease","volume":"383","author":"Anker","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41419-018-1180-y","article-title":"Brain Injury Induces HIF-1\u03b1-dependent Transcriptional Activation of LRRK2 that Exacerbates Brain Damage","volume":"9","author":"Bae","year":"2018","journal-title":"Cell Death Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/ndt\/gfab191","article-title":"Roxadustat for the Treatment of Anaemia in Chronic Kidney Disease Patients Not on Dialysis: A Phase 3, Randomized, Open-Label, Active-Controlled Study (Dolomites)","volume":"36","author":"Barratt","year":"2021","journal-title":"Nephrol. Dial. Transpl."},{"key":"B13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/1091581817737232","article-title":"Evaluation of the Carcinogenic Potential of Roxadustat (Fg-4592), a Small Molecule Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase in Cd-1 Mice and Sprague Dawley Rats","volume":"36","author":"Beck","year":"2017","journal-title":"Int. J. Toxicol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"21276","DOI":"10.1073\/pnas.0903978106","article-title":"Donor Treatment with a Phd-Inhibitor Activating Hifs Prevents Graft Injury and Prolongs Survival in an Allogenic Kidney Transplant Model","volume":"106","author":"Bernhardt","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/ndt\/gfv302","article-title":"Randomized Placebo-Controlled Dose-Ranging and Pharmacodynamics Study of Roxadustat (Fg-4592) to Treat Anemia in Nondialysis-dependent Chronic Kidney Disease (Ndd-Ckd) Patients","volume":"30","author":"Besarab","year":"2015","journal-title":"Nephrol. Dial. Transpl."},{"key":"B16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/ICO.0000000000001430","article-title":"Hypoxia and the Prolyl Hydroxylase Inhibitor Fg-4592 Protect Corneal Endothelial Cells from Mechanical and Perioperative Surgical Stress","volume":"37","author":"Bhadange","year":"2018","journal-title":"Cornea"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1111\/bcp.13584","article-title":"First-in-Man-Proof of Concept Study with Molidustat: A Novel Selective Oral Hif-Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anaemia","volume":"84","author":"B\u00f6ttcher","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1053\/j.ajkd.2015.11.021","article-title":"A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (Gsk1278863) for Anemia in Ckd: A 28-Day, Phase 2a Randomized Trial","volume":"67","author":"Brigandi","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"13274","DOI":"10.1038\/s41598-019-49499-x","article-title":"Hypoxia Activates the Pthrp -Mef2c Pathway to Attenuate Hypertrophy in Mesenchymal Stem Cell Derived Cartilage","volume":"9","author":"Browe","year":"2019","journal-title":"Sci. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/jcpt.13385","article-title":"Long-Term Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Anaemia of Chronic Kidney Disease: A Meta-Analysis Including 13,146 Patients","volume":"46","author":"Chen","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1901713","article-title":"Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis","volume":"381","author":"Chen","year":"","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJMoa1813599","article-title":"Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis","volume":"381","author":"Chen","year":"","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/jnc.12804","article-title":"Hif Prolyl Hydroxylase Inhibition Prior to Transient Focal Cerebral Ischaemia Is Neuroprotective in Mice","volume":"131","author":"Chen","year":"2014","journal-title":"J. Neurochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa2035938","article-title":"Vadadustat in Patients with Anemia and Non-dialysis-dependent Ckd","volume":"384","author":"Chertow","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of Chronic Kidney Disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/term.3165","article-title":"Targeting HIF-\u03b1 for Robust Prevascularization of Human Cardiac Organoids","volume":"15","author":"Coyle","year":"2021","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"18154","DOI":"10.1073\/pnas.0602235103","article-title":"Prolyl Hydroxylase-1 Negatively Regulates Ikappab Kinase-Beta, Giving Insight into Hypoxia-Induced Nfkappab Activity","volume":"103","author":"Cummins","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.20452\/pamw.4445","article-title":"Roxadustat: Another Drug that Causes Pulmonary Hypertension? Report of First Human Case","volume":"129","author":"Cygulska","year":"2019","journal-title":"Pol. Arch. Intern. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"11039","DOI":"10.1021\/acs.jmedchem.6b01242","article-title":"Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia","volume":"59","author":"Debenham","year":"2016","journal-title":"J. Med. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1253\/circj.CJ-19-1039","article-title":"Roxadustat Markedly Reduces Myocardial Ischemia Reperfusion Injury in Mice","volume":"84","author":"Deguchi","year":"2020","journal-title":"Circ. J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/jpet.120.265181","article-title":"Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease","volume":"374","author":"Del Balzo","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/13543784.2018.1417386","article-title":"Roxadustat in the Treatment of Anaemia in Chronic Kidney Disease","volume":"27","author":"Del Vecchio","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s40265-020-01384-y","article-title":"Daprodustat: First Approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"B34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40265-019-01077-1","article-title":"Roxadustat: First Global Approval","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.celrep.2017.02.081","article-title":"PHD2 Targeting Overcomes Breast Cancer Cell Death upon Glucose Starvation in a PP2A\/B55\u03b1-Mediated Manner","volume":"18","author":"Di Conza","year":"2017","journal-title":"Cell Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/gt.2013.32","article-title":"Combination of HIF-1\u03b1 Gene Transfection and HIF-1-Activated Bone Marrow-Derived Angiogenic Cell Infusion Improves Burn Wound Healing in Aged Mice","volume":"20","author":"Du","year":"2013","journal-title":"Gene Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1056\/NEJMoa2025956","article-title":"Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis","volume":"384","author":"Eckardt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1182\/blood-2010-12-324186","article-title":"Activation of Hypoxia-Inducible Factor-1\u03b1 (Hif-1\u03b1) Delays Inflammation Resolution by Reducing Neutrophil Apoptosis and Reverse Migration in a Zebrafish Inflammation Model","volume":"118","author":"Elks","year":"2011","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jhep.2017.01.009","article-title":"Autotaxin-Lysophosphatidic Acid Receptor Signalling Regulates Hepatitis C Virus Replication","volume":"66","author":"Farquhar","year":"2017","journal-title":"J. Hepatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/cmdc.202100133","article-title":"Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat","volume":"16","author":"Figg","year":"2021","journal-title":"ChemMedChem"},{"key":"B41","volume-title":"Fda Roxadustat Briefing Document: Cardiovascular and Renal Drugs Advisory Committee Meeting","year":""},{"key":"B42","volume-title":"Final Summary Minutes of the Cardiovascular and Renal Drugs Advisory Committee Meeting","year":""},{"key":"B43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5966\/sctm.2013-0134","article-title":"Targeting the Hypoxia-Sensing Pathway in Clinical Hematology","volume":"3","author":"Forristal","year":"2014","journal-title":"Stem Cell Transl Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1182\/blood-2012-02-408419","article-title":"Pharmacologic Stabilization of HIF-1\u03b1 Increases Hematopoietic Stem Cell Quiescence In Vivo and Accelerates Blood Recovery after Severe Irradiation","volume":"121","author":"Forristal","year":"2013","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1158\/0008-5472.CAN-18-1785","article-title":"Selective Egln Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer","volume":"79","author":"Fujimoto","year":"2019","journal-title":"Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.molcel.2016.08.014","article-title":"Phd3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of Acc2","volume":"63","author":"German","year":"2016","journal-title":"Mol. Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aad5755","article-title":"Pvhl Suppresses Kinase Activity of Akt in a Proline-hydroxylation-dependent Manner","volume":"353","author":"Guo","year":"2016","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1053\/j.ajkd.2016.12.011","article-title":"Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients with Ckd","volume":"69","author":"Gupta","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/ndt\/gfy055","article-title":"Effects of Vadadustat on Hemoglobin Concentrations in Patients Receiving Hemodialysis Previously Treated with Erythropoiesis-Stimulating Agents","volume":"34","author":"Haase","year":"2019","journal-title":"Nephrol. Dial. Transpl."},{"key":"B50","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1111\/hdi.12567","article-title":"Hif-Prolyl Hydroxylases as Therapeutic Targets in Erythropoiesis and Iron Metabolism","volume":"21","author":"Haase","year":"2017","journal-title":"Hemodial Int."},{"key":"B51","doi-asserted-by":"publisher","first-page":"103506","DOI":"10.1016\/j.resp.2020.103506","article-title":"Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat (Fg-4592) Alleviates Sepsis-Induced Acute Lung Injury","volume":"281","author":"Han","year":"2020","journal-title":"Respir. Physiol. Neurobiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and Management of Retinopathy of Prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.kint.2019.12.007","article-title":"The Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Enarodustat Counteracts Alterations in Renal Energy Metabolism in the Early Stages of Diabetic Kidney Disease","volume":"97","author":"Hasegawa","year":"2020","journal-title":"Kidney Int."},{"key":"B54","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ajh.26397","article-title":"Roxadustat for the Treatment of Anemia in Patients with Lower\u2010risk Myelodysplastic Syndrome: Open\u2010label, Dose\u2010selection, lead\u2010in Stage of a Phase 3 Study","volume":"97","author":"Henry","year":"2021","journal-title":"Am. J Hematol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1189\/jlb.1011518","article-title":"Hif-1 in T Cells Ameliorated Dextran Sodium Sulfate-Induced Murine Colitis","volume":"91","author":"Higashiyama","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global Prevalence of Chronic Kidney Disease - a Systematic Review and Meta-Analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1681\/ASN.2014111139","article-title":"Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor Gsk1278863 for Treatment of Anemia","volume":"27","author":"Holdstock","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1038\/550S193a","article-title":"Non-Union Bone Fracture: A Quicker Fix","volume":"550","author":"Holmes","year":"2017","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fcell.2020.00488","article-title":"Rank Order of Small Molecule Induced Hypoxiamimesis to Prevent Retinopathy of Prematurity","volume":"8","author":"Hoppe","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"E2516","DOI":"10.1073\/pnas.1523005113","article-title":"Comparative Systems Pharmacology of Hif Stabilization in the Prevention of Retinopathy of Prematurity","volume":"113","author":"Hoppe","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B61","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.toxlet.2020.06.009","article-title":"Roxadustat Attenuates Experimental Pulmonary Fibrosis In Vitro and In Vivo","volume":"331","author":"Huang","year":"2020","journal-title":"Toxicol. Lett."},{"key":"B62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bbrc.2012.09.005","article-title":"Prolyl Hydroxylase Domain Protein 2 Regulates the Intracellular Cyclic Amp Level in Cardiomyocytes through its Interaction with Phosphodiesterase 4d","volume":"427","author":"Huo","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B63","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.kint.2019.10.020","article-title":"Prolyl Hydroxylase Inhibition Protects the Kidneys from Ischemia via Upregulation of Glycogen Storage","volume":"97","author":"Ito","year":"2020","journal-title":"Kidney Int."},{"key":"B64","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10571-016-0440-6","article-title":"The Role of Hypoxia-Inducible Factor 1 in Mild Cognitive Impairment","volume":"37","author":"Iyalomhe","year":"2017","journal-title":"Cell Mol Neurobiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/jre.12649","article-title":"Angiopoietin-Like 4 Production upon Treatment with Hypoxia and L-Mimosine in Periodontal Fibroblasts","volume":"54","author":"Janji\u0107","year":"2019","journal-title":"J. Periodontal Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e12909","DOI":"10.1111\/cpr.12909","article-title":"HIF-1\u03b1 Ameliorates Tubular Injury in Diabetic Nephropathy via HO-1-Mediated Control of Mitochondrial Dynamics","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Prolif"},{"key":"B67","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cpdd.83","article-title":"Effect of Food and Gemfibrozil on the Pharmacokinetics of the Novel Prolyl Hydroxylase Inhibitor Gsk1278863","volume":"3","author":"Johnson","year":"2014","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1096\/fj.04-1605fje","article-title":"Persistent Induction of Hif-1alpha and -2alpha in Cardiomyocytes and Stromal Cells of Ischemic Myocardium","volume":"18","author":"J\u00fcrgensen","year":"2004","journal-title":"FASEB J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jphs.2017.12.004","article-title":"Role of Hypoxia-Inducible Factor-1 in the Development of Renal Fibrosis in Mouse Obstructed Kidney: Special References to Hif-1 Dependent Gene Expression of Profibrogenic Molecules","volume":"136","author":"Kabei","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jphs.2019.12.002","article-title":"Effects of Orally Active Hypoxia Inducible Factor Alpha Prolyl Hydroxylase Inhibitor, Fg4592 on Renal Fibrogenic Potential in Mouse Unilateral Ureteral Obstruction Model","volume":"142","author":"Kabei","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"113922","DOI":"10.1016\/j.bcp.2020.113922","article-title":"Hif-1 Stabilization Exerts Anticancer Effects in Breast Cancer Cells In Vitro and In Vivo","volume":"175","author":"Kachamakova-Trojanowska","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1182\/blood-2010-02-270322","article-title":"Hepatic Hif-2 Regulates Erythropoietic Responses to Hypoxia in Renal Anemia","volume":"116","author":"Kapitsinou","year":"2010","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1086\/675990","article-title":"Erythropoietin Upregulation in Pulmonary Arterial Hypertension","volume":"4","author":"Karamanian","year":"2014","journal-title":"Pulm. Circ."},{"key":"B74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1\u03b1 and HIF2\u03b1: Sibling Rivalry in Hypoxic Tumour Growth and Progression","volume":"12","author":"Keith","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"Hif-1-Mediated Expression of Pyruvate Dehydrogenase Kinase: A Metabolic Switch Required for Cellular Adaptation to Hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1172\/JCI83551","article-title":"Distinct Subpopulations of Foxd1 Stroma-Derived Cells Regulate Renal Erythropoietin","volume":"126","author":"Kobayashi","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B77","doi-asserted-by":"publisher","first-page":"10440","DOI":"10.1073\/pnas.0401339101","article-title":"Leukocyte Adhesion during Hypoxia Is Mediated by Hif-1-dependent Induction of Beta2 Integrin Gene Expression","volume":"101","author":"Kong","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B78","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cmet.2009.05.005","article-title":"Activation of a Hif1alpha-Ppargamma Axis Underlies the Integration of Glycolytic and Lipid Anabolic Pathways in Pathologic Cardiac Hypertrophy","volume":"9","author":"Krishnan","year":"2009","journal-title":"Cell Metab"},{"key":"B79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.freeradbiomed.2009.09.025","article-title":"Reduced Oxygen Tension Results in Reduced Human T Cell Proliferation and Increased Intracellular Oxidative Damage and Susceptibility to Apoptosis upon Activation","volume":"48","author":"Larbi","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/s41467-021-23448-7","article-title":"A Small Molecule HIF-1\u03b1 Stabilizer that Accelerates Diabetic Wound Healing","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jphs.2020.09.004","article-title":"Effects of Post-Renal Anemia Treatment with the Hif-Phd Inhibitor Molidustat on Adenine-Induced Renal Anemia and Kidney Disease in Mice","volume":"144","author":"Li","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnagi.2018.00121","article-title":"Therapeutic Potential of a Prolyl Hydroxylase Inhibitor Fg-4592 for Parkinson's Diseases In Vitro and In Vivo: Regulation of Redox Biology and Mitochondrial Function","volume":"10","author":"Li","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"109607","DOI":"10.1016\/j.celrep.2021.109607","article-title":"Macrophage HIF-2\u03b1 Suppresses NLRP3 Inflammasome Activation and Alleviates Insulin Resistance","volume":"36","author":"Li","year":"2021","journal-title":"Cell Rep"},{"key":"B84","doi-asserted-by":"publisher","first-page":"6286984","DOI":"10.1155\/2020\/6286984","article-title":"Pretreatment with Roxadustat (FG-4592) Attenuates Folic Acid-Induced Kidney Injury through Antiferroptosis via Akt\/GSK-3\u03b2\/Nrf2 Pathway","volume":"2020","author":"Li","year":"2020","journal-title":"Oxid Med. Cell Longev"},{"key":"B85","doi-asserted-by":"publisher","first-page":"12630","DOI":"10.1096\/fj.201901087RR","article-title":"The Profibrotic Effects of Mk-8617 on Tubulointerstitial Fibrosis Mediated by the Klf5 Regulating Pathway","volume":"33","author":"Li","year":"2019","journal-title":"FASEB J."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A Comparative Risk Assessment of Burden of Disease and Injury Attributable to 67 Risk Factors and Risk Factor Clusters in 21 Regions, 1990-2010: A Systematic Analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1167\/iovs.15-18066","article-title":"Prolyl-4-Hydroxylases Inhibitor Stabilizes HIF-1\u03b1 and Increases Mitophagy to Reduce Cell Death after Experimental Retinal Detachment","volume":"57","author":"Liu","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10456-017-9592-3","article-title":"Slit2\/Robo1 Signaling Is Involved in Angiogenesis of Glomerular Endothelial Cells Exposed to a Diabetic-like Environment","volume":"21","author":"Liu","year":"2018","journal-title":"Angiogenesis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"104747","DOI":"10.1016\/j.phrs.2020.104747","article-title":"Roxadustat (Fg-4592) Treatment for Anemia in Dialysis-dependent (Dd) and Not Dialysis-dependent (Ndd) Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis","volume":"155","author":"Liu","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.61.3.1","article-title":"The Role of Hypoxia-Inducible Factor 1\u03b1 in the Regulation of Human Meibomian Gland Epithelial Cells","volume":"61","author":"Liu","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000455166","article-title":"Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients","volume":"45","author":"Locatelli","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fphar.2020.01191","article-title":"Antianemia Drug Roxadustat (Fg-4592) Protects against Doxorubicin-Induced Cardiotoxicity by Targeting Antiapoptotic and Antioxidative Pathways","volume":"11","author":"Long","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1091\/mbc.E14-02-0775","article-title":"Phd3-Mediated Prolyl Hydroxylation of Nonmuscle Actin Impairs Polymerization and Cell Motility","volume":"25","author":"Luo","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"B94","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41419-019-1410-y","article-title":"Hypoxia Preconditioning Promotes Bone Marrow Mesenchymal Stem Cells Survival by Inducing HIF-1\u03b1 in Injured Neuronal Cells Derived Exosomes Culture System","volume":"10","author":"Luo","year":"2019","journal-title":"Cell Death Dis"},{"key":"B95","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2215\/CJN.02510218","article-title":"Effects of Molidustat in the Treatment of Anemia in Ckd","volume":"14","author":"Macdougall","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40265-020-01444-3","article-title":"Enarodustat: First Approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"B97","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1159\/000464476","article-title":"Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease","volume":"45","author":"Martin","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3324\/haematol.2011.056119","article-title":"Hepatic Hypoxia-Inducible Factor-2 Down-Regulates Hepcidin Expression in Mice through an Erythropoietin-Mediated Increase in Erythropoiesis","volume":"97","author":"Mastrogiannaki","year":"2012","journal-title":"Haematologica"},{"key":"B99","doi-asserted-by":"publisher","first-page":"11032","DOI":"10.1074\/jbc.M208681200","article-title":"Multiple Splice Variants of the Human Hif-3 Alpha Locus Are Targets of the Von Hippel-Lindau E3 Ubiquitin Ligase Complex","volume":"278","author":"Maynard","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B100","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ceb.2009.11.015","article-title":"Hypoxia-Induced Autophagy: Cell Death or Cell Survival?","volume":"22","author":"Mazure","year":"2010","journal-title":"Curr. Opin. Cell Biol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/ckj\/sfy014","article-title":"Daprodustat for Anemia: A 24-Week, Open-Label, Randomized Controlled Trial in Participants on Hemodialysis","volume":"12","author":"Meadowcroft","year":"2019","journal-title":"Clin. Kidney J."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010037","article-title":"Radioprotective Activity and Preliminary Mechanisms of N-Oxalyl-D-Phenylalanine (Nofd) In Vitro","volume":"20","author":"Meng","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"165842","DOI":"10.1016\/j.bbadis.2020.165842","article-title":"Activation of Hif-1 Signaling Ameliorates Liver Steatosis in Zebrafish Atp7b Deficiency (Wilson's Disease) Models","volume":"1866","author":"Mi","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/0886022X.2021.1915801","article-title":"Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (Fg-4592) Protects against Renal Ischemia\/Reperfusion Injury by Inhibiting Inflammation","volume":"43","author":"Miao","year":"2021","journal-title":"Ren. Fail."},{"key":"B105","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.devcel.2013.06.014","article-title":"Phd1 Links Cell-Cycle Progression to Oxygen Sensing through Hydroxylation of the Centrosomal Protein Cep192","volume":"26","author":"Moser","year":"2013","journal-title":"Dev. Cell"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/ndt\/gfaa060","article-title":"Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, for Treatment of Anemia of Chronic Kidney Disease: Two Randomized Phase 2 Trials in Japanese Patients","volume":"36","author":"Nangaku","year":"2020","journal-title":"Nephrol. Dial. Transpl."},{"key":"B107","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000513103","article-title":"Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial","volume":"52","author":"Nangaku","year":"","journal-title":"Am. J. Nephrol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/1744-9987.13611","article-title":"Vadadustat for Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis: A Phase 3 Open-Label Study in Japan","volume":"25","author":"Nangaku","year":"","journal-title":"Ther. Apher. Dial."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/ndt\/gfab055","article-title":"Efficacy and Safety of Vadadustat Compared with Darbepoetin Alfa in Japanese Anemic Patients on Hemodialysis: A Phase 3, Multicenter, Randomized, Double-Blind Study","volume":"36","author":"Nangaku","year":"","journal-title":"Nephrol. Dial. Transpl."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1681\/ASN.2020091311","article-title":"Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-dependent Ckd","volume":"32","author":"Nangaku","year":"","journal-title":"Jasn"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2337\/db15-0519","article-title":"Hif-1 Mediates Renal Fibrosis in Ove26 Type 1 Diabetic Mice","volume":"65","author":"Nayak","year":"2016","journal-title":"Diabetes"},{"key":"B112","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.isci.2019.08.03310.1016\/j.isci.2019.10.031","article-title":"Controlling the Phenotype of Tumor-Infiltrating Macrophages via the Phd-Hif Axis Inhibits Tumor Growth in a Mouse Model","volume":"21","author":"Nishide","year":"2019","journal-title":"iScience"},{"key":"B113","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jphs.2020.02.010","article-title":"Prolyl-Hydroxylase Inhibitors Reconstitute Tumor Blood Vessels in Mice","volume":"143","author":"Nishide","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"e14434","DOI":"10.14814\/phy2.14434","article-title":"Erythropoietin and a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor (Hif-Phdi) Lowers Fgf23 in a Model of Chronic Kidney Disease (Ckd)","volume":"8","author":"Noonan","year":"2020","journal-title":"Physiol. Rep."},{"key":"B115","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/cpdd.654","article-title":"Randomized Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Topical Daprodustat in Healthy Volunteers and in Patients with Diabetic Foot Ulcers","volume":"8","author":"Olson","year":"2019","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1161\/CIRCULATIONAHA.119.045561","article-title":"Role of Deranged Energy Deprivation Signaling in the Pathogenesis of Cardiac and Renal Disease in States of Perceived Nutrient Overabundance","volume":"141","author":"Packer","year":"2020","journal-title":"Circulation"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.kint.2016.07.019","article-title":"Vadadustat, a Novel Oral Hif Stabilizer, Provides Effective Anemia Treatment in Nondialysis-dependent Chronic Kidney Disease","volume":"90","author":"Pergola","year":"2016","journal-title":"Kidney Int."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1172\/JCI31370","article-title":"Regulation of Iron Homeostasis by the Hypoxia-Inducible Transcription Factors (Hifs)","volume":"117","author":"Peyssonnaux","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1158\/0008-5472.CAN-18-2674","article-title":"Genome-Wide Interrogation of Human Cancers Identifies Egln1 Dependency in Clear Cell Ovarian Cancers","volume":"79","author":"Price","year":"2019","journal-title":"Cancer Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1053\/j.ajkd.2015.12.020","article-title":"Roxadustat (Fg-4592) versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study","volume":"67","author":"Provenzano","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"B121","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.2337\/db14-0472","article-title":"Hif Prolyl 4-Hydroxylase-2 Inhibition Improves Glucose and Lipid Metabolism and Protects against Obesity and Metabolic Dysfunction","volume":"63","author":"Rahtu-Korpela","year":"2014","journal-title":"Diabetes"},{"key":"B122","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1161\/ATVBAHA.115.307136","article-title":"Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects against Development of Atherosclerosis","volume":"36","author":"Rahtu-Korpela","year":"2016","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1172\/JCI30117","article-title":"Hypoxia-Inducible Factor-2 (Hif-2) Regulates Hepatic Erythropoietin In Vivo","volume":"117","author":"Rankin","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41374-019-0239-4","article-title":"Inhibition of Prolyl Hydroxylase Domain (Phd) by Jtz-951 Reduces Obesity-Related Diseases in the Liver, White Adipose Tissue, and Kidney in Mice with a High-Fat Diet","volume":"99","author":"Saito","year":"2019","journal-title":"Lab. Invest."},{"key":"B125","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.ackd.2019.04.004","article-title":"Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience","volume":"26","author":"Sanghani","year":"2019","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.kint.2019.02.016","article-title":"Mononuclear Phagocytes Orchestrate Prolyl Hydroxylase Inhibition-Mediated Renoprotection in Chronic Tubulointerstitial Nephritis","volume":"96","author":"Schley","year":"2019","journal-title":"Kidney Int."},{"key":"B127","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen Sensing by Hif Hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"B128","first-page":"169","article-title":"Stimulating Retinal Blood Vessel Protection with Hypoxia-Inducible Factor Stabilization: Identification of Novel Small-Molecule Hydrazones to Inhibit Hypoxia-Inducible Factor Prolyl Hydroxylase (An American Ophthalmological Society Thesis)","volume":"111","author":"Sears","year":"2013","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1016\/j.celrep.2016.02.047","article-title":"The Oxygen Sensor Phd2 Controls Dendritic Spines and Synapses via Modification of Filamin A","volume":"14","author":"Segura","year":"2016","journal-title":"Cell Rep"},{"key":"B130","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-Inducible Factors in Physiology and Medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"B131","doi-asserted-by":"publisher","first-page":"252","DOI":"10.15252\/embj.201695204","article-title":"Hypoxia-Inducible Factors: Coupling Glucose Metabolism and Redox Regulation with Induction of the Breast Cancer Stem Cell Phenotype","volume":"36","author":"Semenza","year":"2017","journal-title":"EMBO J."},{"key":"B132","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1113\/expphysiol.2006.033498","article-title":"Regulation of Physiological Responses to Continuous and Intermittent Hypoxia by Hypoxia-Inducible Factor 1","volume":"91","author":"Semenza","year":"2006","journal-title":"Exp. Physiol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.exer.2015.06.016","article-title":"Hypoxia Inducible Factor 1\u03b1 Contributes to Regulation of Autophagy in Retinal Detachment","volume":"137","author":"Shelby","year":"2015","journal-title":"Exp. Eye Res."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1093\/ndt\/gfab057","article-title":"Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (Alps)","volume":"36","author":"Shutov","year":"2021","journal-title":"Nephrol. Dial. Transpl."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41598-020-58482-w","article-title":"Hypoxia-Inducible Factor (Hif) Prolyl Hydroxylase Inhibitors Induce Autophagy and Have a Protective Effect in an In-Vitro Ischaemia Model","volume":"10","author":"Singh","year":"2020","journal-title":"Sci. Rep."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa2113380","article-title":"Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis","volume":"385","author":"Singh","year":"","journal-title":"N. Engl. J. Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1056\/NEJMoa2113379","article-title":"Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis","volume":"385","author":"Singh","year":"","journal-title":"N. Engl. J. Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"e129398","DOI":"10.1172\/jci.insight.129398","article-title":"Serine and 1-Carbon Metabolism Are Required for Hif-Mediated Protection against Retinopathy of Prematurity","volume":"4","author":"Singh","year":"2019","journal-title":"JCI Insight"},{"key":"B139","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1167\/iovs.18-24120","article-title":"3-Hydroxypyruvate Destabilizes Hypoxia Inducible Factor and Induces Angiostasis","volume":"59","author":"Singh","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050384","article-title":"Protein Hydroxylation by Hypoxia-Inducible Factor (Hif) Hydroxylases: Unique or Ubiquitous?","volume":"8","author":"Strowitzki","year":"2019","journal-title":"Cells"},{"key":"B141","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.stem.2011.09.010","article-title":"Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche","volume":"9","author":"Suda","year":"2011","journal-title":"Cell Stem Cell"},{"key":"B142","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1681\/ASN.2019060582","article-title":"Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice","volume":"31","author":"Sugahara","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1167\/iovs.13-12171","article-title":"Prolyl Hydroxylase Inhibition during Hyperoxia Prevents Oxygen-Induced Retinopathy in the Rat 50\/10 Model","volume":"54","author":"Trichonas","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B144","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/iej.12307","article-title":"L-mimosine Increases the Production of Vascular Endothelial Growth Factor in Human Tooth Slice Organ Culture Model","volume":"48","author":"Trimmel","year":"2015","journal-title":"Int. Endod. J."},{"key":"B145","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/1744-9987.12962","article-title":"A 24-Week Anemia Correction Study of Daprodustat in Japanese Dialysis Patients","volume":"24","author":"Tsubakihara","year":"2020","journal-title":"Ther. Apher. Dial."},{"key":"B146","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1073\/pnas.0708474105","article-title":"Activation of the Hypoxia-Inducible Factor-1alpha Pathway Accelerates Bone Regeneration","volume":"105","author":"Wan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B147","doi-asserted-by":"publisher","first-page":"58848","DOI":"10.18632\/oncotarget.11585","article-title":"Loss of Prolyl Hydroxylase Domain Protein 2 in Vascular Endothelium Increases Pericyte Coverage and Promotes Pulmonary Arterial Remodeling","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"B148","doi-asserted-by":"publisher","first-page":"490","DOI":"10.7555\/JBR.30.20160110","article-title":"Chronic Intermittent Hypoxia Induces Cardiac Inflammation and Dysfunction in a Rat Obstructive Sleep Apnea Model","volume":"30","author":"Wei","year":"2016","journal-title":"J. Biomed. Res."},{"key":"B149","doi-asserted-by":"publisher","first-page":"109020","DOI":"10.1016\/j.celrep.2021.109020","article-title":"Hypoxic and Pharmacological Activation of Hif Inhibits Sars-Cov-2 Infection of Lung Epithelial Cells","volume":"35","author":"Wing","year":"2021","journal-title":"Cell Rep"},{"key":"B150","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.tibs.2012.10.004","article-title":"Emerging Novel Functions of the Oxygen-Sensing Prolyl Hydroxylase Domain Enzymes","volume":"38","author":"Wong","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e25217","DOI":"10.7554\/eLife.25217","article-title":"HIF-1\u03b1 Is Required for Disturbed Flow-Induced Metabolic Reprogramming in Human and Porcine Vascular Endothelium","volume":"6","author":"Wu","year":"2017","journal-title":"Elife"},{"key":"B152","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2015.12.017","article-title":"Stabilization of HIF-1\u03b1 by FG-4592 Promotes Functional Recovery and Neural protection in Experimental Spinal Cord Injury","volume":"1632","author":"Wu","year":"2016","journal-title":"Brain Res."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1042\/CS20210100","article-title":"Anti-Anemia Drug Fg4592 Retards the Aki-To-Ckd Transition by Improving Vascular Regeneration and Antioxidative Capability","volume":"135","author":"Wu","year":"2021","journal-title":"Clin. Sci. (Lond)"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1172\/JCI80369","article-title":"PHD2\/3-dependent Hydroxylation Tunes Cardiac Response to \u03b2-adrenergic Stress via Phospholamban","volume":"125","author":"Xie","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B155","doi-asserted-by":"publisher","first-page":"ra33","DOI":"10.1126\/scisignal.2000444","article-title":"Oxygen-Regulated Beta(2)-Adrenergic Receptor Hydroxylation by Egln3 and Ubiquitylation by Pvhl","volume":"2","author":"Xie","year":"2009","journal-title":"Sci. Signal."},{"key":"B156","doi-asserted-by":"publisher","first-page":"109175","DOI":"10.1016\/j.biopha.2019.109175","article-title":"Salidroside and Fg-4592 Ameliorate High Glucose-Induced Glomerular Endothelial Cells Injury via Hif Upregulation","volume":"118","author":"Xie","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B157","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cancergen.2014.04.008","article-title":"Over-expression of Prolyl Hydroxylase-1 Blocks NF-\u039ab-Mediated Cyclin D1 Expression and Proliferation in Lung Carcinoma Cells","volume":"207","author":"Xie","year":"2014","journal-title":"Cancer Genet."},{"key":"B158","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1159\/000518072","article-title":"Molidustat for Renal Anemia in Nondialysis Patients Previously Treated with Erythropoiesis-Stimulating Agents: A Randomized, Open-Label, Phase 3 Study","volume":"52","author":"Yamamoto","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"e026704","DOI":"10.1136\/bmjopen-2018-026704","article-title":"Molidustat for the Treatment of Renal Anaemia in Patients with Non-dialysis-dependent Chronic Kidney Disease: Design and Rationale of Two Phase Iii Studies","volume":"9","author":"Yamamoto","year":"2019","journal-title":"BMJ Open"},{"key":"B160","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1042\/CS20171625","article-title":"Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (Fg-4592) Protects against Cisplatin-Induced Acute Kidney Injury","volume":"132","author":"Yang","year":"2018","journal-title":"Clin. Sci. (Lond)"},{"key":"B161","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/nep.13835","article-title":"Recommendations by the Asian Pacific Society of Nephrology (Apsn) on the Appropriate Use of Hif-Ph Inhibitors","volume":"26","author":"Yap","year":"2021","journal-title":"Nephrology (Carlton)"},{"key":"B162","doi-asserted-by":"publisher","first-page":"7651","DOI":"10.1039\/c7sc02103h","article-title":"Molecular and Cellular Mechanisms of Hif Prolyl Hydroxylase Inhibitors in Clinical Trials","volume":"8","author":"Yeh","year":"2017","journal-title":"Chem. Sci."},{"key":"B163","doi-asserted-by":"publisher","first-page":"e133690","DOI":"10.1172\/jci.insight.133690","article-title":"Roxadustat Prevents Ang Ii Hypertension by Targeting Angiotensin Receptors and Enos","volume":"6","author":"Yu","year":"2021","journal-title":"JCI Insight"},{"key":"B164","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1093\/ndt\/gfr754","article-title":"The Balance of Beneficial and Deleterious Effects of Hypoxia-Inducible Factor Activation by Prolyl Hydroxylase Inhibitor in Rat Remnant Kidney Depends on the Timing of Administration","volume":"27","author":"Yu","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"B165","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/cpr.12250","article-title":"Hypoxia Enhances Tenocyte Differentiation of Adipose-Derived Mesenchymal Stem Cells by Inducing Hypoxia-Inducible Factor-1\u03b1 in a Co-culture System","volume":"49","author":"Yu","year":"2016","journal-title":"Cell Prolif"},{"key":"B166","doi-asserted-by":"publisher","first-page":"17384","DOI":"10.1021\/acs.jmedchem.1c01479","article-title":"Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2alpha (Hif-2alpha) Agonist and its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal Anemia","volume":"64","author":"Yu","year":"2021","journal-title":"J. Med. Chem."},{"key":"B167","doi-asserted-by":"publisher","first-page":"10892","DOI":"10.1074\/jbc.M800102200","article-title":"Mitochondrial Autophagy Is an Hif-1-dependent Adaptive Metabolic Response to Hypoxia","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B168","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/1440-1681.13601","article-title":"Roxadustat (FG\u20104592) Protects against Ischaemia\/reperfusion\u2010induced Acute Kidney Injury through Inhibiting the Mitochondrial Damage Pathway in Mice","volume":"49","author":"Zhang","year":"2021","journal-title":"Clin. Exp. Pharma Physio"},{"key":"B169","doi-asserted-by":"publisher","first-page":"L547","DOI":"10.1152\/ajplung.00387.2018","article-title":"Mirna Let-7b Promotes the Development of Hypoxic Pulmonary Hypertension by Targeting Ace2","volume":"316","author":"Zhang","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol Physiol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/aor.13005","article-title":"Donor Treatment with a Hypoxia-Inducible Factor-1 Agonist Prevents Donation after Cardiac Death Liver Graft Injury in a Rat Isolated Perfusion Model","volume":"42","author":"Zhang","year":"2018","journal-title":"Artif. Organs"},{"key":"B171","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.cmet.2019.09.016","article-title":"Adipocyte Hypoxia-Inducible Factor 2\u03b1 Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism","volume":"30","author":"Zhang","year":"2019","journal-title":"Cell Metab"},{"key":"B172","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/22221751.2020.1742585","article-title":"Deficiency of HIF-1\u03b1 Enhances Influenza A Virus Replication by Promoting Autophagy in Alveolar Type II Epithelial Cells","volume":"9","author":"Zhao","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B173","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1161\/ATVBAHA.121.316495","article-title":"Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation","volume":"41","author":"Zhao","year":"2021","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1101\/gad.242131.114","article-title":"Prolyl Hydroxylation by Egln2 Destabilizes Foxo3a by Blocking its Interaction with the Usp9x Deubiquitinase","volume":"28","author":"Zheng","year":"2014","journal-title":"Genes Dev."},{"key":"B175","doi-asserted-by":"publisher","first-page":"e0184049","DOI":"10.1371\/journal.pone.0184049","article-title":"The Prolyl 4-Hydroxylase Inhibitor Gsk360a Decreases Post-Stroke Brain Injury and Sensory, Motor, and Cognitive Behavioral Deficits","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"},{"key":"B176","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.1038\/s41598-019-41924-5","article-title":"The Pro-angiogenic Role of Hypoxia Inducible Factor Stabilizer Fg-4592 and its Application in an In Vivo Tissue Engineering Chamber Model","volume":"9","author":"Zhou","year":"2019","journal-title":"Sci. Rep."},{"key":"B177","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.1096\/fj.201900324RRR","article-title":"Autologous Blood Transfusion Stimulates Wound Healing in Diabetic Mice through Activation of the HIF-1\u03b1 Pathway by Improving the Blood Preservation Solution","volume":"34","author":"Zhu","year":"2020","journal-title":"FASEB J."},{"key":"B178","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/wrr.12708","article-title":"Roxadustat Promotes Angiogenesis through HIF-1\u03b1\/VEGF\/VEGFR2 Signaling and Accelerates Cutaneous Wound Healing in Diabetic Rats","volume":"27","author":"Zhu","year":"2019","journal-title":"Wound Repair Regen."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.837249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T09:04:19Z","timestamp":1645693459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.837249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":178,"alternative-id":["10.3389\/fphar.2022.837249"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.837249","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"article-number":"837249"}}